Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
British Journal of Haematology|September 1, 1992
Type IIB von Willebrand's disease: gene mutations and clinical presentation in nine families from Denmark, Germany and SwedenM Donnér, A C Kristoffersson, H Lenk, et al.
Journal of Pediatric Hematology/Oncology|February 24, 2001
Temporary response of localized intracranial mast cell sarcoma to combination chemotherapyP P Guenther, A Huebner, S B Sobottka, et al.
Archiv Fur Geschwulstforschung|January 1, 1989
[Mitoguazone (methylglyoxal bis(guanylhydrazone))--its status and prospects]H Hoffmann, W Gutsche, R Amlacher, et al.
Seminars in Thrombosis and Hemostasis|December 2, 1998
Molecular markers of the endothelium, the coagulation and the fibrinolytic systems in healthy newbornsR Knöfler, S Hofmann, G Weissbach, et al.
Annals of the New York Academy of Sciences|August 30, 2005
Inhibitor development in patients with hemophilia A after continuous infusion of FVIII concentratesCh von Auer, J Oldenburg, M von Depka, et al.
Seminars in Thrombosis and Hemostasis|May 25, 2001
Thrombolytic therapy in children--clinical experiences with recombinant tissue-plasminogen activatorR Knöfler, J Dinger, M Kabus, et al.
Thrombosis and Haemostasis|February 12, 1999
Inhibitors in German hemophilia A patients treated with a double virus inactivated factor VIII concentrate bind to the C2 domain of FVIII light chainR Laub, M Di Giambattista, P Fondu, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2004
Treatment patterns and cost-of-illness of severe haemophilia in patients with inhibitors in GermanyG Auerswald, M von Depka Prondzinski, B Ehlken, et al.
Annals of Internal Medicine|July 1, 1990
Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study GroupP M Mannucci, K Schimpf, D B Brettler, et al.
Seminars in Oncology|April 1, 1992
A phase II trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinomaE D Kreuser, R U Hilgenfeld, M Matthias, et al.
Pageof 7